First Trust Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $271K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.12M | Buy |
|
|||||
|
2024
Q3 | $1.89M | Buy |
|
|||||
|
2024
Q2 | $196K | Sell |
|
|||||
|
2024
Q1 | $21.8M | Buy |
|
|||||
|
2023
Q4 | $803K | Sell |
|
|||||
|
2023
Q3 | $10.1M | Sell |
|
|||||
|
2023
Q2 | $15.1M | Buy |
|
|||||
|
2023
Q1 | $369K | Buy |
|
|||||
|
2022
Q4 | $228K | Sell |
|
|||||
|
2022
Q3 | $252K | Sell |
|
|||||
|
2022
Q2 | $466K | Sell |
|
|||||
|
2022
Q1 | $2.75M | Sell |
|
|||||
|
2021
Q4 | $16.6M | Sell |
|
|||||
|
2021
Q3 | $51.3M | Buy |
|
|||||
|
2021
Q2 | $61.7M | Buy |
|
|||||
|
2021
Q1 | $46.5M | Sell |
|
|||||
|
2020
Q4 | $44.7M | Buy |
|
|||||
|
2020
Q3 | $6.15M | Buy |
|